Central mineralocorticoid receptors, sympathetic activity, and hypertension

Current Hypertension Reports

Volumn 11, Issue 3, 2009, Pages 224-230

  McManus, Frances ^b   MacKenzie, Scott M ^b   Freel, Marie E ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 2; ALDOSTERONE; ALDOSTERONE SYNTHASE; ALDOSTERONE SYNTHASE INHIBITOR; AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; CARBENOXOLONE; CORTICOSTEROID; CORTICOSTEROID RECEPTOR; CORTICOSTERONE; DIHYDROPYRIDINE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENZYME INHIBITOR; FAD 286; FELODIPINE; GLYCYRRHETINIC ACID; MINERALOCORTICOID ANTAGONIST; MINERALOCORTICOID RECEPTOR; SODIUM; SPIRONOLACTONE; STEROID; UNCLASSIFIED DRUG;

ADRENERGIC SYSTEM; CENTRAL NERVOUS SYSTEM; DRUG MECHANISM; DRUG POTENTIATION; HEART FAILURE; HUMAN; HYPERTENSION; LIGAND BINDING; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PROTEIN STRUCTURE; REVIEW; SODIUM APPETITE; SODIUM BLOOD LEVEL; STEROIDOGENESIS; STRESS; SYMPATHETIC TONE;

ANIMALS; BLOOD PRESSURE; HUMANS; HYPERTENSION; RECEPTORS, MINERALOCORTICOID; SYMPATHETIC NERVOUS SYSTEM;

EID: 65749093613     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-009-0039-0     Document Type: Review

References (50)

1. Morrison N, Harrap SB, Arriza JL, et al.: Regional chromosomal assignment of the human mineralocorticoid receptor gene to 4q31.1. Hum Genet 1990, 85:130-132.
2. Wickert L, Selbig J, Watzka M, et al.: Differential mRNA expression of the two mineralocorticoid receptor splice variants within the human brain: Structure analysis of their different DNA binding domains. J Neuroendocrinol 2000, 12:867-873.
3. Viengchareun S, Le Menuet D, Martinerie L, et al.: The mineralocorticoid receptor: Insights into its molecular and (patho)physiological biology. Nucl Recept Signal 2007, 5:e012.
4. Pratt WB, Toft DO: Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr Rev 1997, 18:306-360.
5. Li Y, Suino K, Daugherty J, Xu HE: Structural and biochemical mechanisms for the specificity of hormone binding and coactivator assembly by mineralocorticoid receptor. Mol Cell 2005, 19:367-380.
6. Meijer OC, Kalkhoven E, van der Juvy LS, et al.: Steroid receptor coactivator-1 splice variants differentially affect corticosteroid receptor signaling. Endocrinology 2005, 146:1438-1448.
7. Rogerson FM, Yao YZ, Elsass RE, et al.: A critical region in the mineralocorticoid receptor for aldosterone binding and activation by cortisol: Evidence for a common mechanism governing ligand binding specificity in steroid hormone receptors. Mol Endocrinol 2007, 21:817-828.
8. Nishi M, Kawata M: Dynamics of glucocorticoid receptor and mineralocorticoid receptor: Implications from live cell imaging studies. Neuroendocrinology 2007, 85:186-192.
9. Seckl JR: 11beta-Hydroxysteroid dehydrogenasA in the brain: a novel regulator of glucocorticoid action? Front Neuroendocrinol 1997, 18:49-99.
10. Roland BL, Li KX, Funder JW: Hybridization histochemical localization of 11beta-hydroxysteroid dehydrogenase type 2 in rat brain. Endocrinology 1995, 136:4697-4700.
11. Geerling JC, Kawata M, Loewy AD: Aldosterone-sensitive neurons in the rat central nervous system. J Comp Neurol 2006, 494:515-527.
12. Clyne CD, Chang CY, Safi R, et al.: Purification and characterization of recombinant human mineralocorticoid receptor. Mol Cell Endocrinol 2009, 302:81-85.
13. de Kloet ER, Vreugdenhil E, Oitzl MS, Joels M: Brain corticosteroid receptor balance in health and disease. Endocr Rev 1998, 19:269-301.
14. De Kloet R, Wallach G, McEwen BS: Differences in corticosterone and dexamethasone binding to rat brain and pituitary. Endocrinology 1975, 96:598-609.
15. Sarabdjitsingh RA, Meijer OC, Schaaf MJM, de Kloet ER: Subregion-specific differences in translocation patterns of mineralocorticoid and glucocorticoid receptors in rat hippocampus. Brain Res 2009, 1249:43-53.
16. Joels M: Functional actions of corticosteroids in the hippocampus. Eur J Pharmacol 2008, 583:312-321.
17. Geerling JC, Loewy AD: Central regulation of sodium appetite. Exp Physiol 2008, 93:177-209.
18. Geerling JC, Loewy AD: Sodium deprivation and salt intake activate separate neuronal subpopulations in the nucleus of the solitary tract and the parabrachial complex. J Comp Neurol 2007, 504:379-403.
19. Cooney AS, Fitzsimons JT: Increased sodium appetite and thirst in rat induced by the ingredients of liquorice, glycyrrhizic acid and glycyrrhetinic acid. Regul Pept 1996, 66:127-133
20. Ye P, Kenyon CJ, Mackenzie SM, et al.: Effects of ACTH, dexamethasone, and adrenalectomy on 11beta-hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2) gene expression in the rat central nervous system. J Endocrinol 2008, 196:305-311
21. Mackenzie SM, Clark CJ, Fraser R, et al.: Expression of 11beta-hydroxylase and aldosterone synthase genes in the rat brain. J Mol Endocrinol 2000, 24:321-328.
22. Gomez-Sanchez CE, Zhou MY, Cozza EN, et al.: Aldosterone biosynthesis in the rat brain. Endocrinology 1997, 138:3369-3373.
23. Mackenzie SM, Clark CJ, Ingram MC, et al.: Corticosteroid production by fetal rat hippocampal neurons. Endocr Res 2000, 26:531-535.
24. Yu L, Romero DG, Gomez-Sanchez CE, Gomez-Sanchez EP: Steroidogenic enzyme gene expression in the human brain. Mol Cell Endocrinol 2002, 190:9-17.
25. MacKenzie SM, Dewar D, Stewart W, et al.: The transcription of steroidogenic genes in the human cerebellum and hippocampus: A comparative survey of normal and Alzheimer's tissue. J Endocrinol 2008, 196:123-130.
26. Huang BS, White RA, Ahmad M, et al.: Central infusion of aldosterone synthase inhibitor prevents sympathetic hyperactivity and hypertension by central Na+ in Wistar rats. Am J Physiol Regul Integr Comp Physiol 2008, 295:R166-R172.
27. Gomez-Sanchez EP, Fort CM, Gomez-Sanchez CE: Intracerebroventricular infusion of RU28318 blocks aldosterone-salt hypertension. Am J Physiol 1990, 258:E482-E484.
28. Gomez-Sanchez EP, Venkataraman MT, Thwaites D, Fort C: ICV infusion of corticosterone antagonizes ICV-aldosterone hypertension. Am J Physiol 1990, 258:E649-E653.
29. Huang BS, White RA, Jeng AY, Leenen FH: Role of CNS aldosterone synthase and mineralocorticoid receptors in salt-induced hypertension in Dahl salt-sensitive rats. Am J Physiol Regul Integr Comp Physiol 2009, 296: R994-R1000.
30. Zhang ZH, Kang YM, Yu Y, et al.: 11beta-hydroxysteroid dehydrogenase type 2 activity in hypothalamic paraventricular nucleus modulates sympathetic excitation. Hypertension 2006, 48:127-133.
31. Bealer SL, Delle M, Skarphedinsson JO, et al.: Differential responses in adrenal and renal nerves to CNS osmotic stimulation. Brain Res Bull 1996, 39:205-209.
32. O'Donaughy TL, Qi Y, Brooks VL: Central action of increased osmolality to support blood pressure in deoxycorticosterone acetate-salt rats. Hypertension 2006, 48:658-663.
33. Duale H, Waki H, Howorth P, et al.: Restraining influence of A2 neurons in chronic control of arterial pressure in spontaneously hypertensive rats. Cardiovasc Res 2007, 76:184-193.
34. Teschemacher AG, Wang S, Raizada MK, et al.: Areaspecific differences in transmitter release in central catecholaminergic neurons of spontaneously hypertensive rats. Hypertension 2008, 52:351-358.
35. Jös M, Karst H, DeRijk R, de Kloet ER: The coming out of the brain mineralocorticoid receptor. Trends Neurosci 2008, 31:1-7.
36. Karst H, Berger S, Turiault M, et al.: Mineralocorticoid receptors are indispensable for nongenomic modulation of hippocampal glutamate transmission by corticosterone. Proc Natl Acad Sci U S A 2005, 102:19204-19207.
37. Losel RM, Wehling M: Classic versus non-classic receptors for nongenomic mineralocorticoid responses: Emerging evidence. Front Neuroendocrinol 2008, 29:258-267.
38. Lai M, Horsburgh K, Bae SE, et al.: Forebrain mineralocorticoid receptor overexpression enhances memory, reduces anxiety and attenuates neuronal loss in cerebral ischaemia. Eur J Neurosci 2007, 25:1832-1842.
39. Derijk RH, Wust S, Meijer OC, et al.: A common polymorphism in the mineralocorticoid receptor modulates stress responsiveness. J Clin Endocrinol Metab 2006, 91:5083-5089.
40. Conway J, Boon N, Jones JV, Sleight P: Involvement of the baroreceptor reflexes in the changes in blood pressure with sleep and mental arousal. Hypertension 1983, 5:746-748.
41. Flaa A, Eide IK, Kjeldsen SE, Rostrup M: Sympathoadrenal stress reactivity is a predictor of future blood pressure: An 18-year follow-up study. Hypertension 2008, 52:336-341.
42. Hogarth AJ, Mackintosh AF, Mary DA: The effect of gender on the sympathetic nerve hyperactivity of essential hypertension. J Hum Hypertens 2007, 21:239-245.
43. Hogarth AJ, Burns J, Mackintosh AF, Mary DA: Sympathetic nerve hyperactivity of essential hypertension is lower in postmenopausal women than men. J Hum Hypertens 2008, 22:544-549.
44. Narkiewicz K, Phillips BG, Kato M, et al.: Gender-selective interaction between aging, blood pressure, and sympathetic nerve activity. Hypertension 2005, 45:522-525.
45. Lipsitz LA, Iloputaife I, Gagnon M, et al.: Enhanced vasoreactivity and its response to antihypertensive therapy in hypertensive elderly women. Hypertension 2006, 47:377-383.
46. Grassi G, Turri C, Dell'Oro R, et al.: Effect of chronic angiotensin converting enzyme inhibition on sympathetic nerve traffic and baroreflex control of the circulation in essential hypertension. J Hypertens 1998, 16:1789-1796.
47. Neumann J, Ligtenberg G, Klein IH, et al.: Sympathetic hyperactivity in hypertensive chronic kidney disease patients is reduced during standard treatment. Hypertension 2007, 49:506-510.
48. Leenen FH, Coletta E, White R: Sympatho-excitatory responses to once-daily dihydropyridines in young versus older hypertensive patients: amlodipine versus felodipine extended release. J Hypertens 2006, 24:177-184.
49. Monahan KD, Leuenberger UA, Ray CA: Aldosterone impairs baroreflex sensitivity in healthy adults. Am J Physiol Heart Circ Physiol 2007, 292:H190-H197.
50. Kasama S, Toyama T, Sumino H, et al.: Additive effects of spironolactone and candesartan on cardiac sympathetic nerve activity and left ventricular remodeling in patients with congestive heart failure. J Nucl Med 2007, 48:1993-2000.